Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

To test the hypothesis that children/adolescents with ADHD, who are treated with atomoxetine hydrochloride in comparison to standard current therapies have greater improvements in their quality of life.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Atomoxetine Hydrochloride

Criteria

Inclusion Criteria:

• Diagnosis of ADHD

Exclusion Criteria:

• Patients who weigh less than 20kg at visit 1

• Have Bipolar Disorder/seizure disorder/taken anticonvulsants for seizures

• Judged to be at suicidal risk

• Taking psychotropic medication on a regular basis

• Hypertension